Multiparametric MRI of the breast: A review
暂无分享,去创建一个
[1] Samuel J. Magny,et al. Breast Imaging Reporting and Data System , 2020, Definitions.
[2] M. Uğurlu,et al. Diagnostic performance of diffusion tensor imaging parameters in breast cancer and correlation with the prognostic factors , 2017, Journal of magnetic resonance imaging : JMRI.
[3] Bin Wang,et al. Intravoxel incoherent motion diffusion-weighted imaging as an adjunct to dynamic contrast-enhanced MRI to improve accuracy of the differential diagnosis of benign and malignant breast lesions. , 2017, Magnetic resonance imaging.
[4] Noam Nissan,et al. Diffusion‐weighted breast MRI: Clinical applications and emerging techniques , 2017, Journal of magnetic resonance imaging : JMRI.
[5] Thomas E Yankeelov,et al. Three-dimensional Image-based Mechanical Modeling for Predicting the Response of Breast Cancer to Neoadjuvant Therapy. , 2017, Computer methods in applied mechanics and engineering.
[6] P. Luijten,et al. Proton and phosphorus magnetic resonance spectroscopy of the healthy human breast at 7 T , 2016, NMR in biomedicine.
[7] T. Noguchi,et al. Diagnostic Performance of Diffusion Tensor Imaging with Readout-segmented Echo-planar Imaging for Invasive Breast Cancer: Correlation of ADC and FA with Pathological Prognostic Markers , 2016, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.
[8] Xiao Li,et al. Diffusion tensor imaging of breast lesions: evaluation of apparent diffusion coefficient and fractional anisotropy and tissue cellularity. , 2016, The British journal of radiology.
[9] J. Joo,et al. Intravoxel incoherent motion diffusion-weighted MR imaging of breast cancer: association with histopathological features and subtypes. , 2016, The British journal of radiology.
[10] E. Morris,et al. Diffusion tensor imaging in the normal breast: influences of fibroglandular tissue composition and background parenchymal enhancement. , 2016, Clinical imaging.
[11] F. Laun,et al. Fast and Noninvasive Characterization of Suspicious Lesions Detected at Breast Cancer X-Ray Screening: Capability of Diffusion-weighted MR Imaging with MIPs. , 2016, Radiology.
[12] Glycerophosphocholine and Glycerophosphoethanolamine Are Not the Main Sources of the In Vivo 31P MRS Phosphodiester Signals from Healthy Fibroglandular Breast Tissue at 7 T , 2016, Front. Oncol..
[13] S. Partridge,et al. Multiparametric MR Imaging of Breast Cancer. , 2016, Magnetic resonance imaging clinics of North America.
[14] Wolfgang Bogner,et al. Quantitative Sodium MR Imaging at 7 T: Initial Results and Comparison with Diffusion-weighted Imaging in Patients with Breast Tumors. , 2016, Radiology.
[15] Martin J. Graves,et al. A comparison of quantitative methods for clinical imaging with hyperpolarized 13C‐pyruvate , 2016, NMR in biomedicine.
[16] M. A. van den Bosch,et al. Dynamic contrast-enhanced breast MRI at 7T and 3T: an intra-individual comparison study , 2016, SpringerPlus.
[17] D. Sodickson,et al. Evaluation of breast cancer using intravoxel incoherent motion (IVIM) histogram analysis: comparison with malignant status, histological subtype, and molecular prognostic factors , 2016, European Radiology.
[18] T. Helbich,et al. A simple scoring system for breast MRI interpretation: does it compensate for reader experience? , 2016, European Radiology.
[19] D. Georg,et al. Multiparametric MRI of the prostate at 3 T: limited value of 3D 1H-MR spectroscopy as a fourth parameter , 2016, World Journal of Urology.
[20] M. Dietzel,et al. Combined reading of Contrast Enhanced and Diffusion Weighted Magnetic Resonance Imaging by using a simple sum score , 2016, European Radiology.
[21] P. Westenend,et al. Multiparametric MRI With Dynamic Contrast Enhancement, Diffusion-Weighted Imaging, and 31-Phosphorus Spectroscopy at 7 T for Characterization of Breast Cancer , 2015, Investigative radiology.
[22] Sylvain Favelier,et al. Current role of multiparametric magnetic resonance imaging for prostate cancer. , 2015, Quantitative imaging in medicine and surgery.
[23] G. Angelelli,et al. Unenhanced breast MRI (STIR, T2-weighted TSE, DWIBS): An accurate and alternative strategy for detecting and differentiating breast lesions. , 2015, Magnetic resonance imaging.
[24] T. Helbich,et al. Breast MRI: EUSOBI recommendations for women’s information , 2015, European Radiology.
[25] Kunwei Shen,et al. Breast Cancer: Diffusion Kurtosis MR Imaging-Diagnostic Accuracy and Correlation with Clinical-Pathologic Factors. , 2015, Radiology.
[26] Thomas E Yankeelov,et al. Multiparametric Magnetic Resonance Imaging for Predicting Pathological Response After the First Cycle of Neoadjuvant Chemotherapy in Breast Cancer , 2015, Investigative radiology.
[27] T. Helbich,et al. Multiparametric MR Imaging with High-Resolution Dynamic Contrast-enhanced and Diffusion-weighted Imaging at 7 T Improves the Assessment of Breast Tumors: A Feasibility Study. , 2015, Radiology.
[28] C. Mountford,et al. Lipid and Metabolite Deregulation in the Breast Tissue of Women Carrying BRCA1 and BRCA2 Genetic Mutations. , 2015, Radiology.
[29] T. Helbich,et al. Quantitative Apparent Diffusion Coefficient as a Noninvasive Imaging Biomarker for the Differentiation of Invasive Breast Cancer and Ductal Carcinoma In Situ , 2015, Investigative radiology.
[30] Lin Li,et al. Parameters of Dynamic Contrast-Enhanced MRI as Imaging Markers for Angiogenesis and Proliferation in Human Breast Cancer , 2015, Medical science monitor : international medical journal of experimental and clinical research.
[31] O. Paulson,et al. Monitoring mammary tumor progression and effect of tamoxifen treatment in MMTV‐PymT using MRI and magnetic resonance spectroscopy with hyperpolarized [1‐13C]pyruvate , 2015, Magnetic resonance in medicine.
[32] T. Helbich,et al. Bilateral diffusion-weighted MR imaging of breast tumors with submillimeter resolution using readout-segmented echo-planar imaging at 7 T. , 2015, Radiology.
[33] S. Choi,et al. Prognosis Prediction of Measurable Enhancing Lesion after Completion of Standard Concomitant Chemoradiotherapy and Adjuvant Temozolomide in Glioblastoma Patients: Application of Dynamic Susceptibility Contrast Perfusion and Diffusion-Weighted Imaging , 2014, PloS one.
[34] Louisa Bokacheva,et al. Intravoxel incoherent motion diffusion‐weighted MRI at 3.0 T differentiates malignant breast lesions from benign lesions and breast parenchyma , 2014, Journal of magnetic resonance imaging : JMRI.
[35] Nico Karssemeijer,et al. A Novel Approach to Contrast-Enhanced Breast Magnetic Resonance Imaging for Screening: High-Resolution Ultrafast Dynamic Imaging , 2014, Investigative radiology.
[36] M. Oudkerk,et al. Effect of b value and pre-admission of contrast on diagnostic accuracy of 1.5-T breast DWI: a systematic review and meta-analysis , 2014, European Radiology.
[37] H. Hricak,et al. Multiparametric 3T MRI for the prediction of pathological downgrading after radical prostatectomy in patients with biopsy-proven Gleason score 3 + 4 prostate cancer , 2014, European Radiology.
[38] Wolfgang Bogner,et al. Improved Differentiation of Benign and Malignant Breast Tumors with Multiparametric 18Fluorodeoxyglucose Positron Emission Tomography Magnetic Resonance Imaging: A Feasibility Study , 2014, Clinical Cancer Research.
[39] T. Helbich,et al. Improved Diagnostic Accuracy With Multiparametric Magnetic Resonance Imaging of the Breast Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging, Diffusion-Weighted Imaging, and 3-Dimensional Proton Magnetic Resonance Spectroscopic Imaging , 2014, Investigative radiology.
[40] T. Helbich,et al. Molecular imaging for the characterization of breast tumors , 2014, Expert review of anticancer therapy.
[41] Wolfgang Bogner,et al. Dynamic Contrast-Enhanced Magnetic Resonance Imaging of Breast Tumors at 3 and 7 T: A Comparison , 2014, Investigative radiology.
[42] Kimberly L Desmond,et al. Mapping of amide, amine, and aliphatic peaks in the CEST spectra of murine xenografts at 7 T , 2014, Magnetic resonance in medicine.
[43] T. Helbich,et al. MRI-only lesions: application of diffusion-weighted imaging obviates unnecessary MR-guided breast biopsies , 2014, European Radiology.
[44] H. Khalil,et al. Improving outcomes of screening breast MRI with practice evolution: Initial clinical experience with 3T compared to 1.5T , 2014, Journal of magnetic resonance imaging : JMRI.
[45] He N. Xu,et al. Is higher lactate an indicator of tumor metastatic risk? A pilot MRS study using hyperpolarized (13)C-pyruvate. , 2014, Academic radiology.
[46] S. Gruber,et al. Clinical application of bilateral high temporal and spatial resolution dynamic contrast-enhanced magnetic resonance imaging of the breast at 7 T , 2014, European Radiology.
[47] Gil Navon,et al. Molecular imaging of tumors and metastases using chemical exchange saturation transfer (CEST) MRI , 2013, Scientific Reports.
[48] J. Gore,et al. Amide proton transfer imaging of the human breast at 7T: development and reproducibility , 2013, NMR in biomedicine.
[49] Xavier Golay,et al. Imaging Brain Deoxyglucose Uptake and Metabolism by Glucocest MRI , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[50] P. Bolan. Magnetic resonance spectroscopy of the breast: current status. , 2013, Magnetic resonance imaging clinics of North America.
[51] Baris Turkbey,et al. Prostate cancer: can multiparametric MR imaging help identify patients who are candidates for active surveillance? , 2013, Radiology.
[52] J. Kurhanewicz,et al. Hyperpolarized [1-13C]Dehydroascorbate MR Spectroscopy in a Murine Model of Prostate Cancer: Comparison with 18F-FDG PET , 2013, The Journal of Nuclear Medicine.
[53] Matthias Dietzel,et al. Breast lesions: diagnosis by using proton MR spectroscopy at 1.5 and 3.0 T--systematic review and meta-analysis. , 2013, Radiology.
[54] D. Parente,et al. Multiparametric magnetic resonance imaging of the prostate. , 2013, Magnetic resonance imaging clinics of North America.
[55] D. Klomp,et al. Ultra high spatial and temporal resolution breast imaging at 7T , 2013, NMR in biomedicine.
[56] K. Pinker,et al. Combined contrast-enhanced magnetic resonance and diffusion-weighted imaging reading adapted to the “Breast Imaging Reporting and Data System” for multiparametric 3-T imaging of breast lesions , 2013, European Radiology.
[57] Les Irwig,et al. Meta-analysis of magnetic resonance imaging in detecting residual breast cancer after neoadjuvant therapy. , 2013, Journal of the National Cancer Institute.
[58] C. Marsault,et al. Diffusion-weighted MR imaging of the breast: advantages and pitfalls. , 2013, European journal of radiology.
[59] H. Schlemmer,et al. CEST-imaging: A new contrast in MR-mammography by means of chemical exchange saturation transfer. , 2012, European journal of radiology.
[60] Peter R Luijten,et al. Quantitative 31P magnetic resonance spectroscopy of the human breast at 7 T , 2012, Magnetic resonance in medicine.
[61] Jie Chen,et al. Can diffusion-weighted MR imaging and contrast-enhanced MR imaging precisely evaluate and predict pathological response to neoadjuvant chemotherapy in patients with breast cancer? , 2012, Breast Cancer Research and Treatment.
[62] R. Ponzone,et al. Correlations between diffusion-weighted imaging and breast cancer biomarkers , 2012, European Radiology.
[63] T. Helbich,et al. Molecular imaging of cancer: MR spectroscopy and beyond. , 2012, European journal of radiology.
[64] Jia Huajie,et al. Can diffusion-weighted MR imaging and contrast-enhanced MR imaging precisely evaluate and predict pathological response to neoadjuvant chemotherapy in patients with breast cancer? , 2012 .
[65] S. Duffy,et al. High resolution MRI of the breast at 3 T: which BI-RADS® descriptors are most strongly associated with the diagnosis of breast cancer? , 2012, European Radiology.
[66] Cecilia Possanzini,et al. 31P MRSI and 1H MRS at 7 T: initial results in human breast cancer , 2011, NMR in biomedicine.
[67] T. Helbich,et al. Three-dimensional proton MR spectroscopic imaging at 3 T for the differentiation of benign and malignant breast lesions. , 2011, Radiology.
[68] Z. Bhujwalla,et al. Choline metabolism in malignant transformation , 2011, Nature Reviews Cancer.
[69] Janet Waters,et al. MRI for breast cancer screening, diagnosis, and treatment , 2011, The Lancet.
[70] Wei Huang,et al. Discrimination of benign and malignant breast lesions by using shutter-speed dynamic contrast-enhanced MR imaging. , 2011, Radiology.
[71] H. Schlemmer,et al. A new contrast in MR mammography by means of chemical exchange saturation transfer (CEST) imaging at 3 Tesla: preliminary results. , 2011, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.
[72] F. Gallagher,et al. Tumor imaging using hyperpolarized 13C magnetic resonance spectroscopy , 2011, Magnetic resonance in medicine.
[73] Thomas E Yankeelov,et al. Magnetic resonance in the era of molecular imaging of cancer. , 2011, Magnetic resonance imaging.
[74] Wendy B DeMartini,et al. Improved diagnostic accuracy of breast MRI through combined apparent diffusion coefficients and dynamic contrast‐enhanced kinetics , 2011, Magnetic resonance in medicine.
[75] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[76] N. deSouza,et al. Functional magnetic resonance: biomarkers of response in breast cancer , 2011, Breast Cancer Research.
[77] Sibel Kul,et al. Contribution of diffusion-weighted imaging to dynamic contrast-enhanced MRI in the characterization of breast tumors. , 2011, AJR. American journal of roentgenology.
[78] Ronald Ouwerkerk,et al. Sodium MRI. , 2011, Methods in molecular biology.
[79] D. Collins,et al. Primary human breast adenocarcinoma: imaging and histologic correlates of intrinsic susceptibility-weighted MR imaging before and during chemotherapy. , 2010, Radiology.
[80] D. Bluemke,et al. Multiparametric magnetic resonance imaging, spectroscopy and multinuclear (²³Na) imaging monitoring of preoperative chemotherapy for locally advanced breast cancer. , 2010, Academic radiology.
[81] Woo Kyung Moon,et al. Diffusion-weighted MR imaging: pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer. , 2010, Radiology.
[82] Thomas E. Yankeelov,et al. Current and Future Trends in Magnetic Resonance Imaging Assessments of the Response of Breast Tumors to Neoadjuvant Chemotherapy , 2010, Journal of oncology.
[83] Bruce Daniel,et al. Detecting blood oxygen level‐dependent (BOLD) contrast in the breast , 2010, Journal of magnetic resonance imaging : JMRI.
[84] Roberto Orecchia,et al. Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group. , 2010, European journal of cancer.
[85] Savannah C Partridge,et al. Diffusion tensor magnetic resonance imaging of the normal breast. , 2010, Magnetic resonance imaging.
[86] Wendy B DeMartini,et al. Diffusion tensor MRI: Preliminary anisotropy measures and mapping of breast tumors , 2010, Journal of magnetic resonance imaging : JMRI.
[87] David A. Bluemke,et al. Diffusion-weighted Imaging Improves the Diagnostic Accuracy of Conventional 3.0-T , 2010 .
[88] Matthias Dietzel,et al. Diffusion tensor magnetic resonance imaging of the breast: a pilot study , 2010, European Radiology.
[89] T. Helbich,et al. Diffusion-weighted MR for differentiation of breast lesions at 3.0 T: how does selection of diffusion protocols affect diagnosis? , 2009, Radiology.
[90] G. Song,et al. Role of hypoxia in the hallmarks of human cancer , 2009, Journal of cellular biochemistry.
[91] Wilma van der Riet,et al. Diffusion-weighted MR imaging with background body signal suppression (DWIBS) for the diagnosis of malignant and benign breast lesions , 2009, European Radiology.
[92] Hiroshi Honda,et al. Enhanced mass on contrast‐enhanced breast MR imaging: Lesion characterization using combination of dynamic contrast‐enhanced and diffusion‐weighted MR images , 2008, Journal of magnetic resonance imaging : JMRI.
[93] John V Frangioni,et al. New technologies for human cancer imaging. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[94] Peter Vaupel,et al. Hypoxia and aggressive tumor phenotype: implications for therapy and prognosis. , 2008, The oncologist.
[95] Daniel B. Vigneron,et al. Current and Potential Applications of Clinical 13C MR Spectroscopy , 2008, Journal of Nuclear Medicine.
[96] Evelyn Wenkel,et al. Diffusion weighted imaging in breast MRI: comparison of two different pulse sequences. , 2007, Academic radiology.
[97] C. Kuhl. The current status of breast MR imaging. Part I. Choice of technique, image interpretation, diagnostic accuracy, and transfer to clinical practice. , 2007, Radiology.
[98] Thomas E Yankeelov,et al. Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial results. , 2007, Magnetic resonance imaging.
[99] Peter Gibbs,et al. Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer. , 2006, Magnetic resonance imaging.
[100] R. Brasch,et al. Magnetic resonance characterization of tumor microvessels in experimental breast tumors using a slow clearance blood pool contrast agent (carboxymethyldextran-A2-Gd-DOTA) with histopathological correlation , 2005, European Radiology.
[101] J. Helpern,et al. Diffusional kurtosis imaging: The quantification of non‐gaussian water diffusion by means of magnetic resonance imaging , 2005, Magnetic resonance in medicine.
[102] D. Yee,et al. Neoadjuvant chemotherapy of locally advanced breast cancer: predicting response with in vivo (1)H MR spectroscopy--a pilot study at 4 T. , 2004, Radiology.
[103] Ning-Yu An,et al. Differentiation of clinically benign and malignant breast lesions using diffusion‐weighted imaging , 2002, Journal of magnetic resonance imaging : JMRI.
[104] D. Le Bihan,et al. Diffusion tensor imaging: Concepts and applications , 2001, Journal of magnetic resonance imaging : JMRI.
[105] T. Helbich,et al. Quantitative gadopentetate‐enhanced MRI of breast tumors: Testing of different analytic methods , 2000, Magnetic resonance in medicine.
[106] F. Podo. Tumour phospholipid metabolism , 1999, NMR in biomedicine.
[107] P Vaupel,et al. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. , 1996, Cancer research.
[108] J. Folkman. Clinical Applications of Research on Angiogenesis , 1995 .
[109] P S Tofts,et al. Quantitative Analysis of Dynamic Gd‐DTPA Enhancement in Breast Tumors Using a Permeability Model , 1995, Magnetic resonance in medicine.
[110] J. Folkman. Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. , 1995, The New England journal of medicine.
[111] Sh. Heywang Kobrunner. Contrast-enhanced magnetic resonance imaging of the breast , 1994 .
[112] O. Linton. [The American College of Radiology]. , 1992, Journal de radiologie.
[113] P. Tofts,et al. Measurement of the blood‐brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts , 1991, Magnetic resonance in medicine.